PRINCETON, N.J.--(BUSINESS WIRE)--CytoCore, Inc. (OTCBB:CYCR), the late-stage bio-scientific research and medical device company for early reproductive cancer treatment, today announced the opening of its new office in this well-known hub for leading-edge solutions to women’s health issues.
